Evaluation and management of pituitary incidentalomas

Cleveland Clinic Journal of Medicine

Volumn 75, Issue 11, 2008, Pages 793-801

  Serhal, Dina ^a   Weil, Robert J ^a   Hamrahian, Amir H ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; CASE REPORT; FEMALE; HUMAN; HYPOPHYSIS APOPLEXY; HYPOPHYSIS TUMOR; INCIDENTAL FINDING; PATHOPHYSIOLOGY; REVIEW;

ADULT; DOPAMINE AGONISTS; FEMALE; HUMANS; INCIDENTAL FINDINGS; PITUITARY APOPLEXY; PITUITARY NEOPLASMS;

EID: 58149460509     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.75.11.793     Document Type: Review

References (30)

1. Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y. A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 2003; 149:123-127.
2. Gsponer J, De Tribolet N, Déruaz JP, et al. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine (Baltimore) 1999; 78:236-269.
3. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer 2004; 101:613-619.
4. Molitch ME, Russell EJ. The pituitary "incidentaloma." Ann Intern Med 1990; 112:925-931.
5. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007; 357:1821-1828.
6. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120:817-820.
7. Karavitaki N, Collison K, Halliday J, et al. What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin Endocrinol (Oxf) 2007; 67:938-943.
8. King JT Jr, Justice AC, Aron DC. Management of incidental pituitary microadenomas: a cost-effectiveness analysis. J Clin Endocrinol Metab 1997; 82:3625-3632.
9. Klibanski A, Zervas NT, Kovacs K, Ridgway EC. Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. J Neurosurg 1987; 66:806-811.
10. Trouillas J, Sassolas G, Loras B, et al. Somatotropic adenomas without acromegaly. Pathol Res Pract 1991; 187:943-949.
11. Cryer PJ, Daughaday WH. Regulation of growth hormone secretion in acromegaly. J Clin Endocrinol Metab 1969; 29:386-393.
12. Reincke M, Allolio B, Saeger W, Menzel J, Winkelmann W. The 'incidentaloma' of the pituitary gland. Is neurosurgery required? JAMA 1990; 263:2772-2776.
13. Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000; 85:526-529.
14. Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC. Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 1997; 314:287-291.
15. Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 2000; 85:1789-1793.
16. Mayenknecht J, Diederich S, Bahr V, Plockinger U, Oelkers W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998; 83:1558-1562.
17. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology 1993; 43:1678-1683.
18. Abe T, Matsumoto K, Kuwazawa J, Toyoda I, Sasaki K. Headache associated with pituitary adenomas. Headache 1998; 38:782-786.
19. Levy MJ, Matharu MS, Meeran K, Powell M, Goadsby PJ. The clinical characteristics of headache in patients with pituitary tumours. Brain 2005; 128:1921-1930.
20. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am 1999; 28:81-117.
21. Gopan T, Toms SA, Prayson RA, Suh JH, Mamrahian AN, Weil RJ. Symptomatic pituitary metastases from renal cell carcinoma. Pituitary 2007; 10:251-259.
22. Moore AF, Grinspoon SK. A dural tale. J Clin Endocrinol Metab 2007; 92:3367-3368.
23. Smirniotopoulos JG, Murphy FM, Rushing EJ, Rees JH, Schroeder JW. Patterns of contrast enhancement in the brain and meninges. Radiographics 2007; 27:525-551.
24. Chanson P, Daujat F, Young J, et al. Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study. J Clin Endocrinol Metab 2001; 86:3009-3015.
25. Donovan LE, Corenblum B. The natural history of the pituitary incidentaloma. Arch Intern Med 1995; 155:181-183.
26. Feldkamp J, Santen R, Harms E, Aulich A, Modder U, Scherbaum WA. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol (Oxf) 1999; 51:109-113.
27. Arita K, Tominaga A, Sugiyama K, et al. Natural course of incidentally field nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 2006; 104:884-891.
28. Tanaka Y, Hongo K, Tada T, Sakai K, Kakizawa Y, Kobayashi S. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 2003; 98:359-365.
29. Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 2001; 71:542-545.
30. Nishizawa S, Ohta S, Yokoyama T, Uemura K. Therapeutic strategy for incidentally found pituitary tumors ("pituitary incidentalomas"). Neurosurgery 1998; 43:1344-1348.